AAAAAA
Results: 51-75/80
Authors:
Poynard, T
Daurat, V
Chevret, S
Moussalli, J
Degos, F
Bailly, F
Borotto, E
Buffet, C
Bartolomei-Portal, I
Richardet, JP
Riachi, G
Calmus, Y
Brechot, C
Vidaud, M
Olivi, M
Bedossa, P
Riffaud, PC
Chastang, C
Citation: T. Poynard et al., A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial, J VIRAL HEP, 6(5), 1999, pp. 381-386
Authors:
Sabile, A
Louha, M
Bonte, E
Poussin, K
Vona, G
Mejean, A
Chretien, Y
Bougas, L
Lacour, BR
Capron, F
Roseto, A
Brechot, C
Paterlini-Brechot, P
Citation: A. Sabile et al., Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection, AM J CLIN P, 112(2), 1999, pp. 171-178
Authors:
Sirma, H
Giannini, C
Poussin, K
Paterlini, P
Kremsdorf, D
Brechot, C
Citation: H. Sirma et al., Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx, ONCOGENE, 18(34), 1999, pp. 4848-4859
Authors:
McIntyre, M
Desdouets, C
Senamaud-Beaufort, C
Laurent-Winter, C
Lamas, E
Brechot, C
Citation: M. Mcintyre et al., Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions, ONCOGENE, 18(32), 1999, pp. 4577-4585
Authors:
Abergel, C
Chenivesse, S
Stinnakre, MG
Guasco, S
Brechot, C
Claverie, JM
Devinoy, E
Christa, L
Citation: C. Abergel et al., Crystallization and preliminary crystallographic study of HIP/PAP, a humanC-lectin overexpressed in primary liver cancers, ACT CRYST D, 55, 1999, pp. 1487-1489
Authors:
Rosmorduc, O
Paterlini, P
Poupon, R
Brechot, C
Citation: O. Rosmorduc et al., Hepatitis viruses and hepatocellular carcinoma., GASTRO CL B, 23(3), 1999, pp. 363-375
Authors:
Bluteau, O
Legoix, P
Bayer, J
Bioulac-Sage, P
Flejou, JF
Capron, F
Monges, G
Brechot, C
Thomas, G
Laurent-Puig, P
Zucman-Rossi, J
Citation: O. Bluteau et al., Semi-automated quantitative method for detecting the loss of heterozygosity at chromosome 4 in hepatocellular carcinoma, GASTRO CL B, 23(11), 1999, pp. 1225-1232
Authors:
Sabile, A
Perlemuter, G
Bono, F
Kohara, K
Demaugre, F
Kohara, M
Matsuura, Y
Miyamura, T
Brechot, C
Barba, G
Citation: A. Sabile et al., Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates, HEPATOLOGY, 30(4), 1999, pp. 1064-1076
Authors:
Bonura, C
Paterlini-Brechot, P
Brechot, C
Citation: C. Bonura et al., Structure and expression of Tg737, a putative tumor suppressor gene, in human hepatocellular carcinomas, HEPATOLOGY, 30(3), 1999, pp. 677-681
Authors:
Loriot, MA
Bronowicki, JP
Lagorce, D
Lakehal, F
Persico, T
Barba, G
Mergey, M
Vons, C
Franco, D
Belghiti, J
Giacca, M
Housset, C
Brechot, C
Citation: Ma. Loriot et al., Permissiveness of human biliary epithelial cells to infection by hepatitisC virus, HEPATOLOGY, 29(5), 1999, pp. 1587-1595
Authors:
Louha, M
Nicolet, J
Zylberberg, H
Sabile, A
Vons, C
Vona, G
Poussin, K
Tournebize, M
Capron, F
Pol, S
Franco, D
Lacour, B
Brechot, C
Paterlini-Brechot, P
Citation: M. Louha et al., Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells, HEPATOLOGY, 29(3), 1999, pp. 879-882
Authors:
Weil, R
Sirma, H
Giannini, C
Kremsdorf, D
Bessia, C
Dargemont, C
Brechot, C
Israel, A
Citation: R. Weil et al., Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappa B inhibitor I kappa B alpha, MOL CELL B, 19(9), 1999, pp. 6345-6354
Authors:
Zylberberg, H
Pol, S
Thiers, V
Chaix, ML
Lagorce, D
Brechot, C
Nalpas, B
Berthelot, P
Citation: H. Zylberberg et al., Significance of repeatedly normal aminotransferase activities in HCV-infected patients, J CLIN GAST, 29(1), 1999, pp. 71-75
Authors:
Zignego, AL
Brechot, C
Citation: Al. Zignego et C. Brechot, Extrahepatic manifestations of HCV infection: facts and controversies, J HEPATOL, 31(2), 1999, pp. 369-376
Authors:
Pol, S
Couzigou, P
Bourliere, M
Abergel, A
Combis, JM
Larrey, D
Tran, A
Moussalli, J
Poupon, R
Berthelot, P
Brechot, C
Citation: S. Pol et al., A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment, J HEPATOL, 31(1), 1999, pp. 1-7
Authors:
Marcellin, P
Alberti, A
Dusheiko, G
Esteban, R
Manns, M
Shouval, D
Weiland, O
Williams, R
Benhamou, JP
Rodes, J
Alter, H
Bismuth, H
Desmet, V
Guardia, J
Heathcote, J
Lok, A
Maddrey, WC
Zum Buschenfelde, KHM
Pagliaro, L
Paumgartner, G
Sherlock, S
Abrignani, S
Alberti, A
Alter, M
Bonino, F
Bortolotti, F
Brechot, C
de Moura, MC
Carreno, V
Colombo, M
Craxi, A
Davis, G
De Francesco, R
Degos, F
Di Bisceglie, A
Dienes, H
Dusheiko, G
Esteban, J
Esteban, R
Farci, P
Ferrari, C
Foster, G
Hadziyannis, S
Hoofnagle, J
Koff, R
Lavanchy, D
Lindsay, K
Lunel, F
Manns, M
Marcellin, P
Mondelli, M
Nalpas, B
Naoumov, N
Pawlotsky, JM
Pol, S
Pontisso, P
Poynard, T
Prieto, J
Rizzetto, M
Roggendorf, M
Moreno, MR
Samuel, D
Sanchez-Tapias, J
Schalm, S
Shouval, D
Simmonds, P
Soriano, V
Tassopoulos, N
Thomas, H
Trepo, C
Van der Poel, CL
Vogel, W
Weiland, O
Wejstal, R
Williams, R
Wright, T
Zanetti, A
Zarski, JP
Zeuzem, S
Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Authors:
Pol, S
Zylberberg, H
Fontaine, H
Brechot, C
Citation: S. Pol et al., Treatment of chronic hepatitis C in special groups, J HEPATOL, 31, 1999, pp. 205-209
Authors:
Brechot, C
Citation: C. Brechot, The direct interplay between HCVNS5A protein and interferon transduction signal: from clinical to basic science, J HEPATOL, 30(6), 1999, pp. 1152-1154
Authors:
Zylberberg, H
Fontaine, H
Thepot, V
Nalpas, B
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Triggering of acute alcoholic hepatitis by alpha-interferon therapy, J HEPATOL, 30(4), 1999, pp. 722-725
Authors:
Zylberberg, H
Rimaniol, AC
Pol, S
Masson, A
De Groote, D
Berthelot, P
Bach, JF
Brechot, C
Zavala, F
Citation: H. Zylberberg et al., Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity, J HEPATOL, 30(2), 1999, pp. 185-191
Authors:
Couillin, I
Pol, S
Mancini, M
Driss, F
Brechot, C
Tiollais, P
Michel, ML
Citation: I. Couillin et al., Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens, J INFEC DIS, 180(1), 1999, pp. 15-26
Authors:
Rosmorduc, O
Sirma, H
Soussan, P
Gordien, E
Lebon, P
Horisberger, M
Brechot, C
Kremsdorf, D
Citation: O. Rosmorduc et al., Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein, J GEN VIROL, 80, 1999, pp. 1253-1262
Authors:
Poussin, K
Dienes, H
Sirma, H
Urban, S
Beaugrand, M
Franco, D
Schirmacher, P
Brechot, C
Brechot, PP
Citation: K. Poussin et al., Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas, INT J CANC, 80(4), 1999, pp. 497-505
Authors:
Zylberberg, H
Thiers, V
Lagorce, D
Squadrito, G
Leone, F
Berthelot, P
Brechot, C
Pol, S
Citation: H. Zylberberg et al., Epidemiological and virological analysis of couples infected with hepatitis C virus, GUT, 45(1), 1999, pp. 112-116
Authors:
Desdouets, C
Thoresen, GH
Senamaud-Beaufort, C
Christoffersen, T
Brechot, C
Sobczak-Thepot, J
Citation: C. Desdouets et al., cAMP-dependent positive control of cyclin A2 expression during G1/S transition in primary hepatocytes, BIOC BIOP R, 261(1), 1999, pp. 118-122